Glucosylated Hybrid TiO 2 /Polymer Nanomaterials for Actively Targeted Sonodynamic Therapy of Cancer
Small · 2024-01 · 20 (4)
DOI: 10.1002/smll.202305475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 15.09.2023. Verfasst von Ivan Zlotver und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaceutical Nanomaterials Science, Department of Materials Science and Engineering, Technion-Israel Institute of Technology, Haifa, …. Hauptthemen laut MEDLINE: Ultrasonic Therapy, Nanoparticles, Rhabdomyosarcoma. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Israel Science Foundation.
Abstract (Originalsprache)
Sonodynamic therapy (SDT) is an anti‐cancer therapeutic strategy based on the generation of reactive oxygen species (ROS) upon local ultrasound (US) irradiation of sono‐responsive molecules or nanomaterials that accumulate in the tumor. In this work, the sonodynamic efficiency of sono‐responsive hybrid nanomaterials composed of amorphous titanium dioxide and an amphiphilic poly(ethylene oxide)‐ b ‐poly(propylene oxide) block copolymer is synthesized, fully characterized, and investigated both in vitro and in vivo. The modular and versatile synthetic pathway enables the control of the nanoparticle size between 30 and 300 nm (dynamic light scattering) and glucosylation of the surface for active targeting of tumors overexpressing glucose transporters. Studies on 2D and 3D rhabdomyosarcoma cell cultures reveal a statistically significant increase in the sonodynamic efficiency of glucosylated hybrid nanoparticles with respect to unmodified ones. Using a xenograft rhabdomyosarcoma murine model, it is demonstrated that by tuning the nanoparticle size and surface features, the tumor accumulation is increased by ten times compared to main off‐target clearance organs such as the liver. Finally, the SDT of rhabdomyosarcoma‐bearing mice is investigated with 50‐nm glucosylated nanoparticles. Findings evidence a dramatic prolongation of the animal survival and tumor volumes 100 times smaller than those treated only with ultrasound or nanoparticles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pharmaceutical Nanomaterials Science, Department of Materials Science and Engineering, Technion-Israel Institute of Technology, Haifa, 3200003, Israel.
ORCID-Profile: Alejandro Sosnik
Förderung
- Israel Science Foundation
Zitieren
APA
Zlotver, I., & Sosnik, A. (2024). Glucosylated Hybrid TiO 2 /Polymer Nanomaterials for Actively Targeted Sonodynamic Therapy of Cancer. Small, 20(4). https://doi.org/10.1002/smll.202305475
Vancouver
Zlotver I, Sosnik A. Glucosylated Hybrid TiO 2 /Polymer Nanomaterials for Actively Targeted Sonodynamic Therapy of Cancer. Small. 2024;20(4). doi:10.1002/smll.202305475
BibTeX
@article{Zlotver2024,
author = {Zlotver, Ivan and Sosnik, Alejandro},
title = {Glucosylated Hybrid TiO 2 /Polymer Nanomaterials for Actively Targeted Sonodynamic Therapy of Cancer},
journal = {Small},
year = {2024},
volume = {20},
number = {4},
doi = {10.1002/smll.202305475}
}
EUVIMED